Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for gestational diabetes
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
A Randomized Controlled Trial to Evaluate the Effects of a Smartphone Application-Based Lifestyle Coaching Program on Gestational Weight Gain, Glycemic Control, Maternal, and Neonatal Outcomes in Women With GestationalDiabetes Mellitus: The SMART-GDM Stu A Randomized Controlled Trial to Evaluate the Effects of a Smartphone Application-Based Lifestyle Coaching Program on Gestational Weight Gain, Glycemic Control, Maternal, and Neonatal Outcomes in Women With GestationalDiabetes Mellitus (...) Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Diabetes Care Actions . 2020 Nov 12;dc201216. doi: 10.2337/dc20-1216. Online ahead of print. A Randomized Controlled Trial to Evaluate the Effects of a Smartphone Application-Based Lifestyle Coaching Program on Gestational Weight Gain, Glycemic Control, Maternal, and Neonatal Outcomes in Women With GestationalDiabetes
Use of metformin hydrochloride in gestationaldiabetes: a systematic review Use of metformin hydrochloride in gestationaldiabetes: a systematic review | Research, Society and Development Open Menu Search Search / / / Review Article Jéssica Costa de Oliveira Faculdade de Enfermagem Nova Esperança de Mossoró Luanne Eugênia Nunes Faculdade de Enfermagem Nova Esperança de Mossoró Franciso Ernesto de Souza Neto Faculdade de Enfermagem Nova Esperança de Mossoró Rosueti Diógenes de Oliveira-Filho (...) Faculdade de Enfermagem Nova Esperança de Mossoró DOI: Keywords: GestationalDiabetes; Metformin; Pregnant women; Systematic review. Abstract GestationalDiabetes Mellitus is a condition characterized by an increase in blood glucose levels, which can be initiated or diagnosed during pregnancy. This process occurs due to the production of high levels of hormones by the placenta, most of which are harmful to the action of insulin in the cells increasing the blood sugar level and can affect the growth
Prevalence of anxiety among gestationaldiabetes mellitus patients: A systematic review and meta-analysis Prevalence of anxiety among gestationaldiabetes mellitus patients: A systematic review and meta-analysis BPG is committed to discovery and dissemination of knowledge This Article Full Article (HTML) (37) Full Article (PDF) (16) Academic Content and Language Evaluation of This Article CrossCheck and Google Search of This Article Academic Rules and Norms of This Article Supplementary (...) Materials of This Article Citation of this article Lee KW, Loh HC, Chong SC, Ching SM, Devaraj NK, Tusimin M, Abdul Hamid H, Hoo FK. Prevalence of anxiety among gestationaldiabetes mellitus patients: A systematic review and meta-analysis. World J Meta-Anal 2020; 8(3): 275-284 Corresponding Author of This Article Siew Mooi Ching, MD, MMed (FamMed), Associate Professor, Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia
Probiotic treatment for women with gestationaldiabetes to improve maternal and infant health and well-being. Gestationaldiabetes mellitus (GDM) is carbohydrate intolerance first recognised during pregnancy and associated with complications for mothers and babies. Probiotics are naturally occurring micro-organisms, which when ingested in adequate amounts, may confer health benefits. Evidence of the role of probiotics as treatment for GDM is limited.To evaluate the safety and effectiveness (...) possible benefit and possible harm. No trials reported primary outcomes of: mode of birth as vaginal/assisted and subsequent development of type 2 diabetes. We are uncertain if probiotics have any effect compared with placebo on induction of labour (RR 1.33, 95% CI 0.74 to 2.37; participants = 127; studies = 1; very low-certainty evidence). For other secondary maternal outcomes, we are uncertain if there are differences between probiotics and placebo for: postpartum haemorrhage; weight gain during
Interventions to prevent women from developing gestationaldiabetes mellitus: an overview of Cochrane Reviews. The prevalence of gestationaldiabetes mellitus (GDM) is increasing, with approximately 15% of pregnant women affected worldwide, varying by country, ethnicity and diagnostic thresholds. There are associated short- and long-term health risks for women and their babies.We aimed to summarise the evidence from Cochrane systematic reviews on the effects of interventions for preventing (...) GDM.We searched the Cochrane Database of Systematic Reviews (6 August 2019) with key words 'gestationaldiabetes' OR 'GDM' to identify reviews pre-specifying GDM as an outcome. We included reviews of interventions in women who were pregnant or planning a pregnancy, irrespective of their GDM risk status. Two overview authors independently assessed eligibility, extracted data and assessed quality of evidence using ROBIS and GRADE tools. We assigned interventions to categories with graphic icons
A systematic review and meta-analysis protocol to compare the risk of attrition among prenatal vitamin D supplemented gestationaldiabetes mellitus patients with its non-recipients. A systematic review and meta-analysis protocol to compare the risk of attrition among prenatal vitamin D supplemented gestationaldiabetes mellitus patients with its non-recipients | medRxiv Search for this keyword A systematic review and meta-analysis protocol to compare the risk of attrition among prenatal vitamin (...) D supplemented gestationaldiabetes mellitus patients with its non-recipients Sumanta Saha doi: https://doi.org/10.1101/2020.05.22.20110262 Sumanta Saha 1 Affiliaton: None For correspondence: ABSTRACT Aim Recently, several clinical trials have tested the effect of prenatal vitamin D supplementation in gestationaldiabetes mellitus (GDM) patients and their newborns. However, their participant attrition, an important determinant of the internal validity, remains poorly explored. Therefore
Progression to type 2 diabetes in women with a known history of gestationaldiabetes: systematic review and meta-analysis. To estimate and compare progression rates to type 2 diabetes mellitus (T2DM) in women with gestationaldiabetes mellitus (GDM) and healthy controls.Systematic review and meta-analysis.Medline and Embase between January 2000 and December 2019, studies published in English and conducted on humans.Observational studies investigating progression to T2DM. Inclusion criteria were (...) postpartum follow-up for at least 12 months, incident physician based diagnosis of diabetes, T2DM reported as a separate outcome rather than combined with impaired fasting glucose or impaired glucose tolerance, and studies with both a group of patients with GDM and a control group.This meta-analysis of 20 studies assessed a total of 1 332 373 individuals (67 956 women with GDM and 1 264 417 controls). Data were pooled by random effects meta-analysis models, and heterogeneity was assessed by use of the I2
Physical exercise and metformin in gestational obesity and prevention on gestationaldiabetes mellitus: a systematic review Physical exercise and metformin in gestational obesity and prevention on gestationaldiabetes mellitus: a systematic review Services on Demand Journal Article text in Indicators Cited by SciELO Related links Similars in SciELO Share Print version ISSN 1519-3829 On-line version ISSN 1806-9304 Rev. Bras. Saude Mater. Infant. vol.20 no.1 Recife Jan./Mar. 2020 Epub May 11 (...) , 2020 REVIEW Physical exercise and metformin in gestational obesity and prevention on gestationaldiabetes mellitus : a systematic review Iramar Baptistella do Nascimento Raquel Fleig Matheus Leite Ramos de Souza Jean Carl Silva 1 Departamento de Pós-graduação em Saúde e Meio Ambiente. Universidade da Região de Joinville. Campus Joinville. Rua Paulo Malschitzki, 10. Zona Industrial Norte. Joinville, SC, Brasil. CEP: 89.219-710. E-mail: firstname.lastname@example.org 2 Departamento de Tecnologia Industrial
BMI: Body Mass Index DM: Diabetes Mellitus GDM: GestationalDiabetes Mellitus gest: gestational age HbA1c: Glycated haemoglobin OGTT: Oral glucose tolerance test =: greater than or equal to : greater than Queensland Clinical Guideline: Gestationaldiabetes mellitus. Guideline No: MN15.33-V1-R20 Assess all women for risk factors GDM care GDM diagnosis OGTT (preferred test for diagnosis) One or more of: • Fasting = 5.1 mmol/L • 1 hour = 10 mmol/L • 2 hour = 8.5 mmol/L HbA1c (if OGTT not suitable (...) • Maternal age = 40 years • Family history DM (1 st degree relative or sister with GDM) • Previous macrosomia (birth weight > 4500 g or > 90 th percentile • Previous perinatal loss • Polycystic Ovarian Syndrome • Medications (corticosteroids, antipsychotics) • Multiple pregnancy Queensland Clinical Guideline: Gestationaldiabetes mellitus Refer to online version, destroy printed copies after use Page 4 of 38 Flowchart: Intrapartum management for GDM requiring Insulin and/or Metformin Metformin • Cease
Serum vitamin D deficiency and risk of gestationaldiabetes mellitus: a meta-analysis Serum vitamin D deficiency and risk of gestationaldiabetes mellitus: a meta-analysis OBSTETRICS AND GYNAECOLOGY / SYSTEMATIC REVIEW/META-ANALYSIS Serum vitamin D deficiency and risk of gestationaldiabetes mellitus: a meta-analysis 1 , 2 , 3 , 4 1 Maternity Department, W.F. Maternity and Child Care Hospital, Weicheng District, China 2 Neonatology Department, Weifang Medical University, Weicheng District (...) , China 3 Pharmacy Department, W.F. Maternity and Child Care Hospital, Weifang, Weicheng District, China 4 Public Computer Center, Weifang Medical University, Weifang, Kuiwen District, China Submission date: 2019-09-20 Final revision date: 2020-02-13 Acceptance date: 2020-02-23 Online publication date: 2020-04-15 Publication date: 2020-05-26 Arch Med Sci 2020;16(4):742–751 KEYWORDS TOPICS ABSTRACT Introduction: This meta-analysis was performed to confirm the relationship of gestationaldiabetes
Fetal biometry for guiding the medical management of women with gestationaldiabetes mellitus for improving maternal and perinatal health. Gestationaldiabetes mellitus (GDM) is a common medical condition that complicates pregnancy and causes adverse maternal and fetal outcomes. At present, most treatment strategies focus on normalisation of maternal blood glucose values with use of diet, lifestyle modification, exercise, oral anti-hyperglycaemics and insulin. This has been shown to reduce (...) the incidence of adverse outcomes, such as birth trauma and macrosomia. However, this involves intensive monitoring and treatment of all women with GDM. We propose that using medical imaging to identify pregnancies displaying signs of being affected by GDM could help to target management, allowing low-risk women to be spared excessive intervention, and facilitating better resource allocation.We wanted to address the following question: in women with gestationaldiabetes, does the use of fetal imaging plus
Efficacy of Fish Oil and/or Probiotic Intervention on the Incidence of GestationalDiabetes Mellitus in an At-Risk Group of Overweight and Obese Women: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial To assess whether the risk of gestationaldiabetes mellitus (GDM) may be lowered and glucose metabolism improved by daily administration of fish oil and/or probiotic supplements in overweight and obese pregnant women.We randomized in a double-blind manner 439 women (mean 13.9 ± 2.1 (...) gestational weeks [gw]) into four intervention groups: fish oil + placebo, probiotics + placebo, fish oil + probiotics, and placebo + placebo. Fish oil (1.9 g docosahexaenoic acid and 0.22 g eicosapentaenoic acid) and probiotic supplements (Lactobacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis 420, 1010 colony-forming units each) were provided for daily consumption from randomization beyond delivery. Primary outcomes were the incidence of GDM diagnosed with oral glucose tolerance test
F1000Prime recommendation of Treatments for gestationaldiabetes: a systematic review and meta-analysis. Treatments for gestationaldiabetes: a systematic... | Faculty Opinions On April 12th, 2020, F1000Prime became Faculty Opinions. See our to learn more. Welcome Guest 1 Recommendations info_outline Systematic Review / Meta-analysis New Finding close Classified As New Finding 1 Article Type Systematic Review / Meta-analysis More more_vert close Download article Export article Sciwheel Download (...) citation BibTeX RIS Share Email Treatments for gestationaldiabetes: a systematic review and meta-analysis. ARTICLE PUBLISHED: 2017 06 24 CITE AS: BMJ Open. 2017 06 24 ; 7 ( 6 ): e015557 Recommendations Abstract Comments You have reached your article limit. Register for 30-day free trial Registration is free and only takes a moment, or subscribe for unlimited access. Already registered with Faculty Opinions? Sign In Institutional access Recommend Faculty Opinions to your librarian or information
Association of Long-term Child Growth and Developmental Outcomes With Metformin vs Insulin Treatment for GestationalDiabetes Metformin is an emerging option for treating gestationaldiabetes (GDM). However, because metformin crosses the placenta, patients and clinicians are concerned with its long-term effect on child health.To estimate the association of treating GDM with metformin vs insulin with child growth and development.Population-based cohort study of New Zealand women treated (...) with metformin or insulin for GDM from 2005 to 2012 and their children. This study linked national health care data to create a cohort of mothers and their children, including data from maternity care, pharmaceutical dispensing, hospitalizations, demographic records, and the B4 School Check (B4SC) preschool health assessment. Women treated pharmacologically with metformin or insulin during pregnancy were included. We excluded pregnancies with evidence of diabetes and deliveries prior to 2013. Liveborn
Clinical and metabolic outcomes in pregnant women at risk for gestationaldiabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs Gestationaldiabetes mellitus is defined as carbohydrate intolerance that begins or is first recognized during pregnancy. Insulin sensitizing substances such as myo-inositol have been considered for the prevention of gestationaldiabetes mellitus and related complications.Because previous studies failed to show a clear reduction (...) of gestationaldiabetes mellitus complications, the aim of this study was to evaluate clinical and metabolic outcomes in women who are at risk for gestationaldiabetes mellitus supplemented with myo-inositol since the first trimester.A secondary analysis of databases from 3 randomized, controlled trials (595 women enrolled) in which women who were at risk for gestationaldiabetes mellitus (a parent with type 2 diabetes mellitus, obese, or overweight) were supplemented with myo-inositol (4 g/d) throughout
A Pre-Pregnancy Biomarker Risk Score Improves Prediction of Future GestationalDiabetes Previous studies have not examined the ability of multiple preconception biomarkers, considered together, to improve prediction of gestationaldiabetes mellitus (GDM).To develop a preconception biomarker risk score and assess its association with subsequent GDM.A nested case-control study among a cohort of women with serum collected as part of a health examination (1984 to 1996) and subsequent pregnancy (...) of diabetes, previous GDM; area under the curve = 0.73 vs 0.67, P = 0.002).The improved, predictive ability of the biomarker risk score beyond established risk factors suggests clinical use of the biomarker risk score in identifying women at risk for GDM before conception for targeted prevention strategies.